World Orphan Drug Congress USA 2025
Join UBC in Boston
We connect specialty therapies to the patients who need them most by delivering modern, customized solutions in access, safety, and evidence generation. Our experts bring ample first-hand knowledge to orphan drugs and rare disease with over 70% of our projects are focused on specialty products or rare diseases. This unique depth of experience enables us to tailor each program to your product and patient requirements.
Connect with our attending team members by completing the form at the right to learn more about our approach and successes in all areas for rare disease and orphan drugs.
Meet Us There
Learn More About UBC
We are dedicated to uniting evidence and access for biopharma. Fill out the form to get in touch with our team and learn more.
Other Events
DIA Global Annual Meeting 2025
ASCO Annual Meeting 2025
Want to know more about us?
Subscribe Now
Want to know more about us?
Subscribe Now
Providers
Meet Us There
Thank You for Connecting with UBC
Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.
What You Can Expect Next
Lorem ipsum dolor sit amet consectetur. Cras aliquam erat eget magna sollicitudin.
- Leverage automation to move fast
- Always give customers a human to chat to
- Automate customer support and close leads faster
Get Ready to Change Your Business
Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.
Service Request
Bekki Bracken Brown
President & Chief Executive Officer
Bekki Bracken Brown serves as the President and CEO of UBC, guiding the company’s mission and values, including the improvement of access for patients to receive better outcomes. She oversees all aspects of UBC, such as operations, business growth strategy, sales and marketing, and acquisition support.
With over 20 years of industry experience, Ms. Brown brings knowledge from a successful career in senior management from her tenure at Quintiles, INC Research, and, most recently, with Syneos Health. She’s been a member of the North Carolina BIO Board of Directors since 2019. She is also a member of the Healthcare Businesswomen’s Association — Southeast Chapter and CHIEF, an organization that supports women executive leaders. Ms. Brown earned her bachelor’s degree at Duke University.